Galux: Series BDevelops AI-driven protein design platform for de novo antibody and drug discoveryOct 4, 2026RoundOSGaluxCompany profile and funding historySourcesbusinesswire.comMore in BiotechAusperBio · Series CProFound Therapeutics · StrategicTransfyr · SeedAIBiotechAsiaSeries B